Anti-RIP3 (phospho S227) antibody [EPR9627]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(116 Publications)
Anti-RIP3 (phospho S227) antibody [EPR9627] (ab209384) is a rabbit monoclonal antibody detecting RIP3 in Western Blot, ELISA, Dot Blot. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 70 publications
View Alternative Names
RIP3, RIPK3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3
- WB
Supplier Data
Western blot - Anti-RIP3 (phospho S227) antibody [EPR9627] (AB209384)
Blocking/Dilution buffer : 5% NFDM/TBST.
Image provided by Xiaodong. Wang, National Institute of Biological Sciences, Beijing.
All lanes:
Western blot - Anti-RIP3 (phospho S227) antibody [EPR9627] (ab209384)
Lane 1:
Untreated HT-29 (Human colorectal adenocarcinoma cell line) whole cell lysate
Lane 2:
HT-29 (Human colorectal adenocarcinoma cell line) treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 uM z-VAD for 6 h and then harvested whole cell lysate
Predicted band size: 57 kDa
Observed band size: 70 kDa
false
- WB
Lab
Western blot - Anti-RIP3 (phospho S227) antibody [EPR9627] (AB209384)
Blocking/Diluting buffer and concentration 5% NFDM/TBST
All lanes:
Western blot - Anti-RIP3 (phospho S227) antibody [EPR9627] (ab209384) at 1/1000 dilution
Lane 1:
HT-29 (Human colorectal adenocarcinoma epithelial cell) treated with 20 ng/ml TNF alpha, 100 nM Smac mimetic and 20μM VAD-FMK for 6 h cell lysate at 10 µg
Lane 2:
HT-29 (Human colorectal adenocarcinoma epithelial cell) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 70 kDa
false
Exposure time: 100s
- ELISA
Lab
ELISA - Anti-RIP3 (phospho S227) antibody [EPR9627] (AB209384)
Direct ELISA antibody dose-response curve using ab209384. Antigen concentration of 1000 ng/mL and primary antibody concentration of 0-1000 ng/mL. A Alkaline Phosphatase-conjugated AffiniPure -conjugated goat anti-rabbit IgG (1/2500) was used as the secondary antibody.
- Dot
Supplier Data
Dot Blot - Anti-RIP3 (phospho S227) antibody [EPR9627] (AB209384)
Dot blot analysis of RIP3 (phospho S227) phospho peptide (Lane 1) and RIP3 non-phospho peptide (Lane 2) labeled using ab209384 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/100,000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 10 seconds.
Related conjugates and formulations (1)
-
Anti-RIP3 (phospho S227) antibody [EPR9627] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-RIP3 (phospho S227) antibody [EPR9627] (ab209384) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), ELISA, Dot Blot in Human samples.
What is the molecular weight of RIP3?
Anti-RIP3 (phospho S227) [EPR9627] (ab209384) specifically detects a band for RIP3 (UniProt: Q9Y572) at a molecular weight of 57kDa.
Trusted by the scientific community
Anti-RIP3 (phospho S227) [EPR9627] (ab209384) was first used in a scientific publication in 2015 and has been cited over 70 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR9627] also available for your convenience: ab209384, Carrier free - ab240383
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (116)
Recent publications for all applications. Explore the full list and refine your search
Cell death discovery 11:413 PubMed40877228
2025
Applications
Unspecified application
Species
Unspecified reactive species
Research (Washington, D.C.) 8:0823 PubMed40822127
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 53:737-753 PubMed40801020
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:7360 PubMed40783390
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:7309 PubMed40774959
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:345 PubMed40715038
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:426 PubMed40456737
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1586705 PubMed40458801
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pathogens (Basel, Switzerland) 14: PubMed40430799
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40332549
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com